Geoffrey Otton

2.2k total citations
20 papers, 397 citations indexed

About

Geoffrey Otton is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Geoffrey Otton has authored 20 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Obstetrics and Gynecology and 5 papers in Reproductive Medicine. Recurrent topics in Geoffrey Otton's work include Endometrial and Cervical Cancer Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Genetic factors in colorectal cancer (3 papers). Geoffrey Otton is often cited by papers focused on Endometrial and Cervical Cancer Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Genetic factors in colorectal cancer (3 papers). Geoffrey Otton collaborates with scholars based in Australia, Germany and United States. Geoffrey Otton's co-authors include Rodney J. Scott, Anthony Proietto, Ian Symonds, Katie A. Ashton, Mark McEvoy, John Attia, Ute Hamann, Michael Gilbert, Kelly‐Anne Phillips and Michael Quinn and has published in prestigious journals such as SHILAP Revista de lepidopterología, BJOG An International Journal of Obstetrics & Gynaecology and Gynecologic Oncology.

In The Last Decade

Geoffrey Otton

19 papers receiving 387 citations

Peers

Geoffrey Otton

ONCOL

MB

OG

RM

CR

Tamara Kalir United States

L. Rom South Africa

Olivier Marpeau France

Maarit Vuento Finland

Takahiro Mizutani Japan

Tomoko Hirakawa Japan

M F Segers Netherlands

Xiaochuan Xie China

Sunamchok Srijaipracharoen Thailand

Francesca Colonese Italy

Tamara Kalir United States

Geoffrey Otton

71 ×0.6

ONCOL

87 ×0.8

MB

271 ×2.9

OG

243 ×2.9

RM

70 ×0.9

CR

Citations per year, relative to Geoffrey Otton Geoffrey Otton (= 1×) peers Tamara Kalir

Countries citing papers authored by Geoffrey Otton

Since Specialization

Citations

This map shows the geographic impact of Geoffrey Otton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Otton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Otton more than expected).

Fields of papers citing papers by Geoffrey Otton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Otton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Otton. The network helps show where Geoffrey Otton may publish in the future.

Co-authorship network of co-authors of Geoffrey Otton

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Otton. A scholar is included among the top collaborators of Geoffrey Otton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Otton. Geoffrey Otton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Seib, Charrlotte, Emma Harbeck, Debra Anderson, et al.. (2024). Establishing the sensitivity and specificity of the gynaecological cancer distress screen. Psycho-Oncology. 33(3). e6328–e6328.

2.

Day, Tania, et al.. (2021). Erosive Lichen Sclerosus—A Clinicopathologic Subtype. Journal of Lower Genital Tract Disease. 25(3). 255–260. 3 indexed citations

3.

Scurry, James, Geoffrey Otton, Kenneth Jaaback, et al.. (2018). Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer. Gynecologic Oncology. 151(2). 306–310. 12 indexed citations

4.

Talia, Karen L., Geoffrey Otton, Suzanne M. Garland, Samuel Phillips, & James Scurry. (2017). Human Papillomavirus–Associated Adenocarcinoma In Situ of the Vestibule. Journal of Lower Genital Tract Disease. 21(4). e45–e47. 3 indexed citations

5.

Pringle, Kirsty G., Sarah J. Delforce, Yu Wang, et al.. (2016). Renin–angiotensin system gene polymorphisms and endometrial cancer. Endocrine Connections. 5(3). 128–135. 22 indexed citations

6.

Talseth‐Palmer, Bente A., Denis C. Bauer, Wenche Sjursen, et al.. (2016). Targeted next‐generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families. Cancer Medicine. 5(5). 929–941. 19 indexed citations

7.

Delforce, Sarah J., Eugenie R. Lumbers, Yu Wang, et al.. (2016). Expression of renin–angiotensin system (RAS) components in endometrial cancer. Endocrine Connections. 6(1). 9–19. 46 indexed citations

8.

Ashton, Katie A., James Scurry, Sepehr N. Tabrizi, et al.. (2015). The problem of late ovarian metastases from primary cervical adenocarcinoma. SHILAP Revista de lepidopterología. 13. 23–25. 6 indexed citations

9.

Scurry, James, et al.. (2013). Genital melanocytic naevus and lichen sclerosus. Pathology. 45(6). 616–618. 4 indexed citations

10.

Ashton, Katie A., Anthony Proietto, Geoffrey Otton, et al.. (2010). Toll-Like Receptor (TLR) and Nucleosome-binding Oligomerization Domain (NOD) gene polymorphisms and endometrial cancer risk. BMC Cancer. 10(1). 382–382. 52 indexed citations

11.

Ashton, Katie A., Anthony Proietto, Geoffrey Otton, et al.. (2010). Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk. Cancer Epidemiology. 34(3). 328–337. 49 indexed citations

12.

Ashton, Katie A., Anthony Proietto, Geoffrey Otton, et al.. (2009). Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer. Gynecologic Oncology. 113(1). 109–114. 43 indexed citations

13.

Ashton, Katie A., Anthony Proietto, Geoffrey Otton, Ian Symonds, & Rodney J. Scott. (2009). Genetic variants in MUTYH are not associated with endometrial cancer risk. Hereditary Cancer in Clinical Practice. 7(1). 3–3. 15 indexed citations

14.

Proietto, Anthony, Geoffrey Otton, Ian Symonds, et al.. (2009). Estrogen receptor polymorphisms and the risk of endometrial cancer. BJOG An International Journal of Obstetrics & Gynaecology. 116(8). 1053–1061. 38 indexed citations

15.

Otton, Geoffrey, et al.. (2009). Intravenous Leiomyomatosis with Intracardiac Extension: First Reported Case in Australia. Heart Lung and Circulation. 19(1). 50–52. 18 indexed citations

16.

Ashton, Katie A., Anthony Proietto, Geoffrey Otton, et al.. (2008). The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor. BMC Cancer. 8(1). 272–272. 10 indexed citations

17.

Farrell, Rhonda, James Scurry, Geoffrey Otton, & Neville F. Hacker. (2005). Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium. Gynecologic Oncology. 98(2). 254–262. 13 indexed citations

18.

Otton, Geoffrey, Shane Higgins, Kelly‐Anne Phillips, & Michael Quinn. (2001). A case of early-stage epithelial ovarian cancer in pregnancy. International Journal of Gynecological Cancer. 11(5). 413–417. 3 indexed citations

19.

Otton, Geoffrey, Shane Higgins, Kelly‐Anne Phillips, & Michael Quinn. (2001). A case of early-stage epithelial ovarian cancer in pregnancy. International Journal of Gynecological Cancer. 11(5). 413–417. 34 indexed citations

20.

Otton, Geoffrey, et al.. (1997). Large Meningioma Complicating Pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology. 37(4). 466–469. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact